Delivery Order SPE2DB22D3004-SPE2DB26FQ93C
- Not listed
- The Defense Logistics Agency has awarded a delivery order valued at $10,743.66 to AmerisourceBergen Drug Corp for the supply of GAMUNEX-C 20 gram/200 mL vials. This firm fixed price delivery order, issued on November 3, 2025, with completion scheduled for November 25, 2025, is being fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order valued at $11,801.40 to AmerisourceBergen Drug Corp for GAMUNEX-C 20 gram/200 mL vials on September 29, 2025, with completion scheduled for October 21, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to the contractor's facility in Conshohocken,...
- The Defense Logistics Agency awarded a $1,220.94 firm fixed-price delivery order to AmerisourceBergen Drug Corp for GAMUNEX-C 10 Gram/100 ML vials totaling 100 ML. The award, issued on July 21, 2025, with an ultimate completion date of August 11, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical supply vendor serving military and veteran...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of GAMUNEX-C 20 gram/200 milliliter vials valued at $11,651.54 under a firm fixed-price contract with an ultimate completion date of August 18, 2025. This non-set-aside award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for GAMUNEX-C 20 gram/200 milliliter vials valued at $11,801.40 with firm fixed pricing. This is a non-set-aside delivery order with an ultimate completion date of September 3, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, is executing this...
- The Defense Logistics Agency awarded a $28,323.12 firm fixed-price delivery order to AmerisourceBergen Drug Corp for GAMUNEX-C 20 gram/200 milliliter vials with an ultimate completion date of August 22, 2025. This non-set-aside competitive award was issued on August 1, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of GAMUNEX-C 5 gram/50 milliliter vials valued at $3,036.70. This non-set-aside, firm fixed-price delivery order will be completed by October 9, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal military and...
- The Defense Logistics Agency awarded a $40,532.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp for GAMUNEX-C 20 gram/200 milliliter vials, with an ultimate completion date of August 22, 2025. This competitively awarded, non-set-aside contract represents a child delivery order under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical distributor,...
- The Defense Logistics Agency awarded a $13,963.20 delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of GAMUNEX-C 40 gram/400 milliliter vials with a completion date of September 23, 2025. This firm fixed-price contract, issued without set-aside designation, represents a competitive award to the major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The delivery order is structured as a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, valued at $7,920.46, for 10 grams of GAMUNEX-C in 100 milliliter vials on September 2, 2025. This is a firm fixed-price delivery order with no set-aside designation, reflecting open competition. The contract is set to complete on September 23, 2025, and represents performance at the vendor's location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB26FQ93CDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,220.96 to AmerisourceBergen Drug Corp for GAMUNEX-C 10 gram/100 mL vials on November 10, 2025, with completion scheduled for December 3, 2025. This is a firm fixed-price, non-set-aside contract performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vehicle that runs through December 2026 and serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, is a critical federal vendor specializing in medical procurement for military and veteran healthcare systems. The company's portfolio includes brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This delivery order for GAMUNEX-C, an immunoglobulin product used for immune deficiency treatment, exemplifies the company's role in supplying specialized pharmaceutical products to support Defense Health Agency and other government healthcare systems. All of AmerisourceBergen's reviewed federal contract awards have been competitively awarded through open competition, demonstrating its capability to meet rigorous federal procurement standards.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 11/10/25 |